JENNIFER SMITH: Open Payments
NPI 1811260821 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$59,543 in 200 payments from 15 companies in 2025. Trend: 2023 $24,214 · 2024 $23,004 · 2025 $59,543
Speaker / faculty: $37,454Travel & lodging: $11,502Food & beverage: $5,306Consulting: $5,233Education: $48
| Company | Payments | Amount |
|---|---|---|
| EMD Serono, Inc. | 67 | $38,858 |
| GENZYME CORPORATION | 11 | $6,868 |
| Biogen, Inc. | 22 | $6,048 |
| Genentech USA, Inc. | 12 | $5,204 |
| TG Therapeutics, Inc. | 31 | $1,300 |
| Novartis Pharmaceuticals Corporation | 20 | $441 |
| Amgen Inc. | 10 | $248 |
| ABBVIE INC. | 8 | $166 |
| ANI Pharmaceuticals, Inc. | 4 | $112 |
| Teva Pharmaceuticals USA, Inc. | 3 | $72 |
Products named: Mavenclad, VUMERITY, Ocrevus, BRIUMVI, TYSABRI, KESIMPTA, UPLIZNA, PURIFIED CORTROPHIN GEL.
Industry payments across OK — which companies pay providers there.
